It is a energy and power private limited company based in Bengaluru, Karnataka, India, established in 2015.
2015 | Bengaluru, Karnataka, India | ActiveDover Pharmaceuticals Private Limited, a active private limited company, was established on 21 October 2015 in Bengaluru, Karnataka, India. Engaging in power transmission & distribution services within the energy and power sector, it holds CIN: U40100KA2015PTC083584. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Sara Kamal (Director), Sanah Kamal (Director), Sabah Kamal (Director). Past directors included Sara Kamal, Syed Fahad, Syed Abdul Ahad. It holds ₹20.00 Cr open charges and no settled loans. Its latest AGM occurred on 06 September 2025, with the balance sheet filed on 31 March 2025. It is based at No. 324, Golden Point 4, 1St Floor, Off Queens Road Cross, Vasant, H Nagar,, Bengaluru, Karnataka, 560052.
U40100KA2015PTC083584
083584
21 October 2015
₹0.10 M
₹0.10 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Dover Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sara Kamal | Director | 30 Jul 2018 | Current |
| Sanah Kamal | Director | 24 Aug 2022 | Current |
| Sabah Kamal | Director | 24 Aug 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 25 Sep 2022 | Past |
| Pramod Abcsdd | Managing Director | 10 Jun 2022 | Past |
| Pramod Abcsdd | Director | 26 Aug 2022 | Past |
| Pramod Abcsdd | Additional Director | 26 Sep 2022 | Past |
| Pramod Abcsdd | Director | 26 Aug 2022 | Past |
| Pramod Abcsdd | Additional Director | 26 Sep 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Dover Pharmaceuticals Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 26.56% decrease in profit. The company's net worth observed a substantial decline by a decrease of 56.06%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Dover Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹200,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Aug 2024 | Others | ₹20.00 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Dover Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Dover Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dover Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Dover Pharmaceuticals Private Limited last Annual general meeting of members was held on 06 Sep 2025 as per latest MCA records. was documented.
Progress on Dover Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore. was documented.
A charge with Others amounted to Rs. 200.00 M with Charge ID 100984780 was registered on 31 Aug 2024. was recorded as a recent event.
Progress on Sanah Kamal was appointed as a Director was appointed as a Director on 24 Aug 2022 & has been associated with this company since 3 years 4 months . was documented.
The activity Sabah Kamal was appointed as a Director was appointed as a Director on 24 Aug 2022 & has been associated with this company since 3 years 4 months . was completed.
The activity Sara Kamal was appointed as a Director was appointed as a Director on 30 Jul 2018 & has been associated with this company since 7 years 4 months . was completed.
The CIN of Dover Pharmaceuticals Private Limited is U40100KA2015PTC083584.
Dover Pharmaceuticals Private Limited is headquartered at No. 324, Golden Point 4, 1St Floor, Off Queens Road Cross, Vasant, H Nagar,, Bengaluru, Karnataka, 560052.
Dover Pharmaceuticals Private Limited was incorporated on 21 October 2015.
The current directors of Dover Pharmaceuticals Private Limited are
The primary industry of Dover Pharmaceuticals Private Limited is Energy And Power.
Dover Pharmaceuticals Private Limited is unlisted.
The authorized capital of Dover Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Dover Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX